Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.